[Immunogenic properties of the liposomal form of the rabies vaccine]. 1988

S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ

The liposomal form of inactivated cultural whole-virion rabies vaccine was shown to induce formation of more intensive immunity than the vaccine without liposomes. These data have been obtained in immunity challenge by intracerebral inoculation of fixed virus as well as intramuscular inoculation of street rabies virus.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
January 1990, Vestnik Akademii meditsinskikh nauk SSSR,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
February 1990, Veterinarni medicina,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
January 1993, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
April 1984, Lancet (London, England),
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
December 1977, Journal of immunology (Baltimore, Md. : 1950),
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
May 2015, Vaccine,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
January 1945, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
March 1942, Journal of bacteriology,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
January 1990, Radiobiologiia,
S V Gribencha, and G D Kobrinskiĭ, and S A Safarov, and L V Vuchetich, and I F Barinskiĭ
February 1981, Immunology,
Copied contents to your clipboard!